• Mira Smart Conferencing
  • Home
  • Table of Contents
  • Advanced Search
 
Advanced Search

Browse All

Current Filters

CLEAR FILTER x

TITLE

Topic:

  • Neuromuscular and Clinical Neurophysiology (EMG)

Filter

Partial Search: Partial searches may be entered manually by pressing enter in the filter input field.
Author Filter: Selecting one or more Authors from the Author drop down list will filter results by Author last name(s) only.

Displaying 26 - 30 of 247

  • Page:
  • 4
  • 5
  • 6
  • 7
  • 8

Efficacy and Safety of Efgartigimod in Anti-acetylcholine Receptor Antibody–Negative Generalized Myasthenia Gravis: Initial Results of ADAPT SERON

Author:Howard, James   Vu, Tuan   Zhao, Chongbo   Luo, Sushan   Hoffmann, Sarah   Claeys, Kristl   Jimenez, Rosa   Seghers, Ineke   Masschaele, Delphine   Huang, Wan-Yi   Rzepinski, Lukasz   Chroni, Elisabeth   Alshehri, Ali Mohammed   Breiner, Ari   

Session Name:S14: Updates on Myasthenia Gravis  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S14.008  

Author Institution:The University of North Carolina, NC  University of South Florida Morsani College of Medicine, FL  Huashan Hospital, Fudan University, China, People's Republic of  Charité – Universitätsmedizin Berlin, Germany  University Hospitals Leuven  and KU Leuven, Belgium  argenx, Belgium  10th Military Research Hospital and Polyclinic  and University of Science and Technology, Poland  University Hospital of Patras, Greece  King Faisal Specialist Hospital and Research Centre, Saudi Arabia  The Ottawa Hospital/The University of Ottawa, ON, Canada  

  • View Abstract
  • View Disclosure

Myasthenia Gravis Inebilizumab Trial (MINT): Efficacy, Pharmacodynamics, and Immunogenicity in AChR+ Cohort (Week 52)

Author:Clarkson, Kristen   Utsugisawa, Kimiaki   Benatar, Michael   Ciafaloni, Emma   Leite, Maria   Vissing, John   Tang, Fengming   Peer, Cody J.   Cheng, Sue   Howard, James   Nowak, Richard   

Session Name:S14: Updates on Myasthenia Gravis  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S14.009  

Author Institution:Amgen Inc., CA  Hanamaki General Hospital, Hanamaki, Japan  University of Miami, Miami, FL  University of Rochester Medical Center, Rochester, NY  Nuffield Department of Clinical Neurosciences - University of Oxford, Oxford, United Kingdom  University of Copenhagen, Copenhagen, Denmark  The University of North Carolina, Dept of Neurology, Chapel Hill, NC  Yale University School of Medicine, New Haven, CT  

  • View Abstract
  • View Disclosure

Preclinical Characterization of MGAC-007, a First-in-Class Antigen Drug Conjugate for AChR+ Myasthenia Gravis

Author:Oved, Kfir   Denkberg, Galit   Reef, Sharon   Arman, Inbar   Pinzur, Lena   Mazor, Roei D.   Harel, Ofer   Erez, Shir   Atiya, Yael   Dowery, Reem   Benatar, Michael   De Baets, Marc   Wolfe, Gil   Kaminski, Henry   

Session Name:S14: Updates on Myasthenia Gravis  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:S14.010  

Author Institution:Canopy Immunotherapeutics, Megadim, Israel  Canopy Immunotherapeutics, Tzukei Yam, Israel  Canopy Immunotherapeutics, Haifa, Israel  University of Miami, Miami, FL  Maastricht University, Netherlands  Univ. At Buffalo, SUNY, Buffalo, NY  George Washington University, Washington, DC  

  • View Abstract
  • View Disclosure

Comparative Performance of Electrodiagnostic Criteria in Guillain-Barré Syndrome and the Impact of Machine-assisted Analysis

Author:Oh, Jee Eun   Skolka, Michael   Swart, Grace   Schipani, Elke   Shelly, Shahar   Stålberg, Stefan   Stålberg, Benjamin   Gardner, Abe   Price, Jacob   Dubey, Divyanshu   Pinto, Marcus Vinicius   Hass, Reece   Mandrekar, Jayawant   Laughlin, Ruple   Litchy, William   Klein, Christopher   

Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Autoimmune Neuropathies  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P1.001  

Author Institution:Mayo Clinic Rochester, Rochester, MN  Mayo Clinic Jacksonville, FL  Royal Prince Alfred Hospital, Darlinghurst, Australia  Rambam Medical Center, Haifa, Israel  Cadwell Industries, Kennewick, WA  Mayo Clinic Rochester, Saint Paul, MN  

  • View Abstract
  • View Disclosure

Impact of Subcutaneous Efgartigimod PH20 on Treatment-naïve Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in the ADHERE Trial: Post Hoc Analyses

Author:Allen, Jeffrey   Katzberg, Hans   Gwathmey, Kelly   Kaida, Ken-ichi   Kuwabara, Satoshi   Hussain, Yessar   De Roeck, Arne   Van Hoorick, Benjamin   Istas, Geoffrey   Lewis, Richard   

Session Name:P1: Neuromuscular and Clinical Neurophysiology (EMG): Autoimmune Neuropathies  

Topic:Neuromuscular and Clinical Neurophysiology (EMG)  

Program Number:P1.002  

Author Institution:University of Minnesota, Minneapolis, MN  Ottawa hospital research institute, Ottawa, ON, Canada  Virginia Commonwealth University, Richmond, VA  Saitama Medical Center, Saitama Medical University, Kawagoe, Japan  Graduate School of Medicine, Chiba University, Chiba, Japan  Austin Neuromuscular Center, Austin, TX  argenx, Ghent, Belgium  Cedars-Sinai Medical Center, Los Angeles, CA  

  • View Abstract
  • View Disclosure

Displaying 26 - 30 of 247

  • Page:
  • 4
  • 5
  • 6
  • 7
  • 8

© 2015 Mira Smart Conference | http://www.mirasmart.com